You are not currently logged in.
Access JSTOR through your library or other institution:
Cryptococcal Meningitis in Patients with AIDS
William E. Dismukes
The Journal of Infectious Diseases
Vol. 157, No. 4 (Apr., 1988), pp. 624-628
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/30136987
Page Count: 5
You can always find the topics here!Topics: AIDS, Cryptococcal meningitis, Antigens, Cryptococcosis, Infectious diseases, Dosage, Relapse, Nervous system diseases, Central nervous system diseases, Mycoses
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Note from Dr. Merle A. Sande. The Cryptococcus has become a major cause of meningitis in patients infected with the human immunodeficiency virus (HIV), and the expression of cryptococcal infection in this population of patients is quite unique. Often the infection is devoid of inflammatory response and is associated with very high antigen and fungal titers. Response to amphotericin therapy is erratic, and relapse is common. We have asked Dr. William E. Dismukes, principal investigator of the NIAID Mycoses Study Group, to discuss the following clinical questions: When and how does cryptococcal infection in HIV-infected patients present? How does it differ in HIV-infected and non-HIV-infected individuals? How is the diagnosis established? What is the sensitivity of the CSF cryptococcal antigen test? Is the serum antigen test of any value? What is the best way to treat patients-the recommended drugs, dosages, and duration of therapy? Is maintenance therapy necessary, and finally, what drugs are available for it?
The Journal of Infectious Diseases © 1988 Oxford University Press